174 related articles for article (PubMed ID: 3052644)
21. Fluosol-DA as a red-cell substitute in acute anemia.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
[TBL] [Abstract][Full Text] [Related]
22. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
Nishimura N; Sugi T
Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of Fluosol-DA in acute cerebral ischemia.
Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
[TBL] [Abstract][Full Text] [Related]
24. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
25. Biocompatibility studies with a novel perfluorochemical emulsion.
Bollands AD; Lowe KC; Sharma SK; Davis SS
Biomater Artif Cells Artif Organs; 1988; 16(1-3):451-3. PubMed ID: 3179482
[TBL] [Abstract][Full Text] [Related]
26. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
Brown AS; Reichman JH; Spence RK
Ann Plast Surg; 1984 May; 12(5):449-53. PubMed ID: 6742725
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with Fluosol-DA (20%) in the United States.
Tremper KK; Levine EM; Waxman K
Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
[No Abstract] [Full Text] [Related]
28. Perfluorocarbon-based red blood cell substitutes.
Biro GP
Transfus Med Rev; 1993 Apr; 7(2):84-95. PubMed ID: 8481603
[TBL] [Abstract][Full Text] [Related]
29. (Pyridoxylated hemoglobin)-(polyoxyethylene) conjugate solution as blood substitute for normothermic whole body rinse-out.
Agishi T; Funakoshi Y; Honda H; Yamagata K; Kobayashi M; Takahashi M
Biomater Artif Cells Artif Organs; 1988; 16(1-3):261-70. PubMed ID: 3179468
[TBL] [Abstract][Full Text] [Related]
30. Perfluorochemical artificial blood as a volume expander in hypoxemic respiratory failure in dogs.
Light RB; Perez-Padilla R; Kryger MH
Chest; 1987 Mar; 91(3):444-9. PubMed ID: 3816321
[TBL] [Abstract][Full Text] [Related]
31. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
[TBL] [Abstract][Full Text] [Related]
32. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
[TBL] [Abstract][Full Text] [Related]
33. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
[No Abstract] [Full Text] [Related]
34. Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion.
Keipert PE
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):381-94. PubMed ID: 7493059
[TBL] [Abstract][Full Text] [Related]
35. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions].
Labrude P
Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671
[TBL] [Abstract][Full Text] [Related]
36. Assessment of a 35% fluorocarbon emulsion.
Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
[TBL] [Abstract][Full Text] [Related]
37. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
38. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
[TBL] [Abstract][Full Text] [Related]
39. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
Ravis WR; Hoke JF; Parsons DL
Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
Nishimura N; Hiranuma N; Sugi T
Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
